Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).

Simon JA, Lin F, Vittinghoff E, Bittner V; Heart and Estrogen-Progestin Replacement Study (HERS) Research Group.

Ann Epidemiol. 2006 Feb;16(2):138-45. Epub 2005 Jul 21.

PMID:
16039873
[PubMed - indexed for MEDLINE]
2.

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.

JAMA. 1998 Aug 19;280(7):605-13.

PMID:
9718051
[PubMed - indexed for MEDLINE]
3.

Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.

Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB.

JAMA. 2000 Apr 12;283(14):1845-52.

PMID:
10770146
[PubMed - indexed for MEDLINE]
4.

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064.

PMID:
12090862
[PubMed - indexed for MEDLINE]
5.

Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).

Shlipak MG, Chaput LA, Vittinghoff E, Lin F, Bittner V, Knopp RH, Hulley SB; Heart and Estrogen/progestin Replacement Study Investigators.

Am Heart J. 2003 Nov;146(5):870-5.

PMID:
14597937
[PubMed - indexed for MEDLINE]
6.

Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.

Grady D, Applegate W, Bush T, Furberg C, Riggs B, Hulley SB.

Control Clin Trials. 1998 Aug;19(4):314-35.

PMID:
9683309
[PubMed - indexed for MEDLINE]
7.

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators.

JAMA. 2002 Jul 17;288(3):321-33.

PMID:
12117397
[PubMed - indexed for MEDLINE]
8.

Estrogen plus progestin and the risk of coronary heart disease.

Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M; Women's Health Initiative Investigators.

N Engl J Med. 2003 Aug 7;349(6):523-34.

PMID:
12904517
[PubMed - indexed for MEDLINE]
Free Article
9.

Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?

Shlipak MG, Stehman-Breen C, Vittinghoff E, Lin F, Varosy PD, Wenger NK, Furberg CD; Heart and Estrogen/Progestin Replacement Study (HERS) Investigators.

Am J Kidney Dis. 2004 Jan;43(1):37-44.

PMID:
14712425
[PubMed - indexed for MEDLINE]
10.

Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.

Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.

Acta Obstet Gynecol Scand. 2004 Jul;83(7):661-6.

PMID:
15225192
[PubMed - indexed for MEDLINE]
11.

Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.

Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM.

J Am Coll Cardiol. 1999 Jun;33(7):2030-7.

PMID:
10362210
[PubMed - indexed for MEDLINE]
Free Article
12.
13.

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

JAMA. 2002 Jul 3;288(1):58-66.

PMID:
12090863
[PubMed - indexed for MEDLINE]
14.

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial.

Toh S, Hernández-Díaz S, Logan R, Rossouw JE, Hernán MA.

Ann Intern Med. 2010 Feb 16;152(4):211-7. doi: 10.7326/0003-4819-152-4-201002160-00005.

PMID:
20157135
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK.

Am Heart J. 1998 Jul;136(1):115-24. Erratum in: Am Heart J 1999 Oct;138(4 Pt 1):800.

PMID:
9665228
[PubMed - indexed for MEDLINE]
16.

Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy.

Rossouw JE, Cushman M, Greenland P, Lloyd-Jones DM, Bray P, Kooperberg C, Pettinger M, Robinson J, Hendrix S, Hsia J.

Arch Intern Med. 2008 Nov 10;168(20):2245-53. doi: 10.1001/archinte.168.20.2245.

PMID:
19001202
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.

Nair GV, Chaput LA, Vittinghoff E, Herrington DM; Heart and Estrogen/Progestin Replacement Study Investigators.

Chest. 2005 May;127(5):1498-506.

PMID:
15888820
[PubMed - indexed for MEDLINE]
19.

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA, Kruyer W, Gotto AM Jr.

JAMA. 1998 May 27;279(20):1615-22.

PMID:
9613910
[PubMed - indexed for MEDLINE]
20.

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D.

N Engl J Med. 2000 Aug 24;343(8):522-9.

PMID:
10954759
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk